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INTRODUCTION
Receptor-like protein-tyrosine phosphatases (RPTPs) form a
diverse family of transmembrane enzymes that play roles in
cell adhesion and cell signaling (Brady-Kalnay and Tonks,
1995; den Hertog et al., 1999). The LAR (Leukocyte Common
Antigen Related) protein is the founding member of a
subfamily of RPTPs known as type IIa RPTPs, defined by
extracellular domains composed of immunoglobulin-like and
fibronectin type III (FNIII) domains. The extracellular domain
of LAR thus resembles those of cell adhesion proteins such as
N-CAM, implying that it links cell adhesion and intracellular
tyrosine phosphorylation.
Vertebrate genomes contain at least three LAR-like RPTP
genes: LAR, PTP d , and PTP s . All three generate multiple
protein isoforms by tissue-specific alternative splicing, and are
expressed in complex patterns in many ectodermal and
endodermal epithelia and in neural tissues (Pulido et al., 1995;
Stoker and Dutta, 1998). In non-neuronal cells LAR family
members localize to focal adhesions (Serra-Pagès et al., 1995),
adherens junctions (Aicher et al., 1997) and regions in contact
with basal laminae. In neurons, LAR family members are
found on cell bodies, processes and growth cones, suggesting
a role in modulating cell adhesion during axon outgrowth
(Zhang et al., 1998; Zhang and Longo, 1995). The Drosophila
LAR ortholog Lar (previously known as Dlar), is mostly
expressed in the nervous system (Krueger et al., 1996),
although expression in oogenesis has also been observed
(Fitzpatrick et al., 1995).
The most detailed analysis of RPTP function in vivo has
been in Drosophila. In mutants lacking Lar some motor axons
bypass their correct target area, reflecting a failure in
defasciculation at the point where the axons choose to extend
into the muscle (Krueger et al., 1996). Lar is also required
for normal target recognition by axons from retinal
photoreceptors; in Lar mutants, these axons retract from their
normal target layer, suggesting a role for Lar in recognition or
adhesion to target layer cells (Clandinin et al., 2001; Maurel-
Zaffran et al., 2001). Different defasciculation or outgrowth
defects are seen in fly mutants lacking other RPTPs (Desai et
al., 1996; Garrity et al., 1999; Sun et al., 2000a). The axonal
phenotypes observed in Lar mutants are incompletely
penetrant, likely because other RPTPs can substitute for loss
of Lar function (Desai et al., 1997). Thus, in Drosophila, Lar
functions to modulate cell adhesion during axon growth;
several likely components of the Lar pathway have recently
been identified based on their interactions with Lar in growth
cone guidance (Bateman et al., 2000; Wills et al., 1999). Lar
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Receptor-like protein-tyrosine phosphatases (RPTPs) form
a diverse family of cell surface molecules whose functions
remain poorly understood. The LAR subfamily of RPTPs
has been implicated in axon guidance and neural
development. Here we report the molecular and genetic
analysis of the C. elegans LAR subfamily member PTP-3.
PTP-3 isoforms are expressed in many tissues in early
embryogenesis, and later become localized to neuronal
processes and to epithelial adherens junctions. Loss of
function in ptp-3 causes low-penetrance defects in
gastrulation and epidermal development similar to those of
VAB-1 Eph receptor tyrosine kinase mutants. Loss of
function in ptp-3 synergistically enhances phenotypes of
mutations in the C. elegans Eph receptor VAB-1 and a
subset of its ephrin ligands, but does not show specific
interactions with several other RTKs or morphogenetic
mutants. The genetic interaction of vab-1 and ptp-3 suggests
that LAR-like RPTPs and Eph receptors have related and
partly redundant functions in C. elegans morphogenesis.
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has also recently been found to play roles in early embryonic
morphogenesis in Drosophila, where it functions in
polarization of somatic follicle cells (Bateman et al., 2001;
Frydman and Spradling, 2001).
Mice lacking Lar have defects in mammary gland
development (Schaapveld et al., 1997) and in glucose
homeostasis (Ren et al., 1998), and have mild defects in the
CNS (Yeo et al., 1997). Mice lacking PTP s display mild neural
and epithelial defects, including a slight decrease in brain size
and reduction in the size of the posterior pituitary (Elchebly et
al., 1999; Wallace et al., 1999); the cellular basis of these
defects is unknown. PTP d mutant mice display defects in
spatial learning, yet show no neuroanatomical defects (Uetani
et al., 2000).
The C. elegans genome contains 26 receptor protein-
tyrosine phosphatases, including orthologs of most major
vertebrate RPTP classes (Plowman et al., 1999; Wälchli et al.,
2000). We report here the characterization of PTP-3, the
C. elegans ortholog of the LAR subfamily. We identify a loss-
of-function mutation in ptp-3, and show that this mutation
causes defects in epidermal and early neural morphogenesis,
although axon morphology in selected neurons appears normal.
Epidermal and neural morphogenesis also require signaling via
the C. elegans Eph receptor VAB-1 and its ephrin ligands
(Chin-Sang et al., 1999; George et al., 1998; Wang et al., 1999).
We find that ptp-3 and Eph signaling mutations show specific
synergistic effects on morphogenesis. Our results suggest that
in C. elegans PTP-3/LAR and VAB-1/Eph RTK pathways
play partly redundant roles in morphogenesis, and raise the
possibility that LAR type RPTPs and Eph RTKs play
redundant roles in other animals.
MATERIALS AND METHODS
C. elegans genetics
C. elegans worms were cultured as described by Brenner (Brenner,
1974), at 20°C unless stated otherwise. Mutations used were: LGII:
vab-1(e2, e116, e118, e699, dx31, e2027, tn2), clr-1(e1745ts),
tra-2(q122dm), unc-4(e120), sqt-1(sc1sd); LGIII: ina-1(gm119),
daf-2(e1370); LGIV: efn-1/vab-2(ju1), efn-2(ev658). LGX:
egl-15(n484), efn-3(ev696). Rearrangements used were: LGII:
mnDf57, mnDf83, mnDf89, mnDf90, mnC1, mIn1 (previously known
as mC6). Mutations not referenced in the text have been previously
described (Riddle et al., 1997).
We constructed vab-1 ptp-3 double mutants by recombination.
Typically, progeny of vab-1 unc-4/ ptp-3 heterozygotes were screened
for Vab non-Unc recombinants. Recombinants were homozygosed, if
possible, and presence of the op147 Tc1 insertion confirmed by PCR.
Inviable double mutants were maintained heterozygous to the
balancer chromosomes mnC1 or mIn1 (Edgley and Riddle, 2001).
mIn1 balances the vab-1 to ptp-3 interval; a version of mIn1
containing the GFP transgene mIs14 were also used in later genetic
constructions.
To construct double mutants with unlinked mutations of similar
phenotypes, and to obtain balanced strains in the event of a synthetic-
lethal interaction, we used the mIn1 mIs14 balancer, or other dominant
markers on LGII to follow the ptp-3(+) chromosome. For example,
to make ptp-3; ina-1 double mutants we crossed tra-2(q122gf) males
with ptp-3 hermaphrodites and obtained ptp-3/tra-2 male cross
progeny, which we mated with sqt-1; ina-1 animals. The non-male F1
progeny of this cross are either Roller females, of genotype
tra-2(q122)/sqt-1; ina-1/+, or are Roller hermaphrodites, of genotype
ptp-3/sqt-1; ina-1/+. Such Rol F1 hermaphrodites were selfed and Rol
Egl F2 animals selected, putatively homozygous for ina-1 and
heterozygous for ptp-3 (balanced over sqt-1). Non-Dpy Non-Rol F3
progeny were picked, putatively ptp-3; ina-1, and their progeny
checked by PCR for homozygosity of the op147 insertion.
Quantitation of lethality and statistical analysis of differences in
lethality between strains were performed as described previously
(Chin-Sang et al., 1999). For viable strains shown in Fig. 7, at least
three complete broods (>500 animals) were quantitated with the aid
of a dissecting microscope. For balanced synthetic-lethal strains,
estimations of lethality were based on counts of eggs spot-checked
using Nomarski microscopy; heterozygous animals and balancer
homozygotes were viable and excluded from counts based on
expression of the mIs14 transgene. The vab-1 alleles dx31, e2027, ju8,
tn2, e856, e118 and e116 caused 100% lethality in combination with
ptp-3(op147), as determined by counts of strains of genotype vab-1
ptp-3/mIn1 mIs14.
ptp-3/deficiency heterozygote analysis
The following chromosomal deficiencies failed to complement op147,
based on the presence of the Ptp-3 morphology defects in cross-
progeny resulting from crosses of op147 or op147/+ males with
deficiency heterozygotes: mnDf83, mnDf89, mnDf90. The deficiency
mnDf57 complemented op147. To estimate the penetrance of lethal
and morphological defects in op147/Df heterozygotes, we first
generated strains in which the deficiencies were balanced in trans to
mIn1 mIs14. Animals of genotype Df/mIn1 mIs14 were feminized by
feeding them bacteria expressing RNA for the fem-1 gene, resulting
in dsRNA-mediated interference (RNAi) of the endogenous fem-1
gene (Timmons and Fire, 1998). Bacterial strain HT115, harboring
the fem-1 RNAi plasmid, was grown on NGM agar plates containing
1-10 mM IPTG and 25 m g/ml carbenicillin. One to two days later, L4
parental animals of genotype Df/mIn1 mIs14 were placed on the plate.
Feminized progeny were crossed with op147 males; all non-GFP-
expressing progeny from such a cross are of genotype op147/Df. The
penetrance of lethal phenotypes in such animals was quantitated at
20°C as described above. Animals of genotype op147/mnDf90
displayed 6.9% embryonic lethality and 3.3% larval morphology
defects (n=360).
RNA interference of ptp-3
A 1.3 kb AccI-SacI fragment from the ptp-3 cDNA, corresponding to
the C terminus of the intracellular domain, was subcloned into the
L4440 RNAi vector. This construct was linearized to allow in vitro
synthesis of the plus and minus strands in separate reactions (Promega
Riboprobe Combination System-T7/T3). The reactions were
combined and the resulting dsRNA (approx. 0.75-1 m g/m l) was
injected into the gonad or gut of N2 hermaphrodites. The broods of
18 injected animals were scored for embryonic lethal and larval
morphological defects; embryonic lethality in such broods averaged
4.6% (range 0 to 20.6%); larval abnormalities averaged 1.1% (range
0 to 9.1%).
Four-dimensional microscopy
Timelapse microscopy in multiple focal planes (four-dimensional, 4-
D) was performed as described previously (Chin-Sang et al., 1999).
Movies were recorded at room temperature (approx. 22-23°C). We
recorded movies from 37 op147 embryos and 30 vab-1(e2) op147
embryos derived from homozygous strains grown at 20°C. From
balanced strains of genotype vab-1 ptp-3(op147)/mIn1 we recorded
movies from eleven vab-1(dx31) ptp-3(op147) embryos and six
vab-1(e2027) ptp-3(op147) embryos.
Cloning and molecular analysis of ptp-3
To analyze transcripts from ptp-3 we made poly(A)+ mRNA from
approximately 80 m g of total RNA isolated from mixed stage N2
animals. This RNA was electrophoresed in a 1.5% formaldehyde
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agarose gel and blotted using standard procedures (Sambrook et al.,
1989). The blot was hybridized with a 32P-labeled ptp-3B cDNA.
We isolated a cDNA encoding the PTP-3B isoform by screening a
l ZAP library (kindly provided by R. Barstead) with a PTP-3 PCR
clone. Primers PTP1-5 (5¢ CCCGAAGCGCCCGAGATCG) and
PTP1-6 (5¢ CGGTTCCGTCGACTGTCTTCGCC) were used in PCRs
using cosmid F38A3 as template, yielding the expected 183 bp ptp-3
PCR fragment. This fragment was labeled with [ a -32P]dATP and
[a -32P]dCTP, and used to screen approx. 100,000 plaques using
standard procedures (Sambrook et al., 1989). Three positives were
identified and their inserts isolated. The longest ptp-3 cDNA
contained a 5 ¢ UTR of 80 bp, a coding region of 4461 bp, and a 3¢
UTR of 467 bp.
We used RT-PCR to generate cDNA clones of the PTP-3A
transcript. For cDNA synthesis, we used primer oBH-18 (exon 18)
(5¢ TCGTACTGAACATCAATCGGTTCAC 3 ¢ ) as the anchor primer.
We carried out the RT reaction at 37°C for 1 hour using 6 m g of total
N2 RNA, the anchor primer, and Superscript II Reverse Transcriptase
(Gibco BRL). To amplify the fragments we used Vent DNA
Polymerase (New England Biolabs) and the oBH-18 cDNA template
in PCR reactions with the following combinations of primers.
To make the 847 bp fragment corresponding to exons 13-18,
excluding 14, we used the oBH-18 primer in combination with primer
oBH-19 (5 ¢ AGTACGACGAGGATATGGACG3 ¢ ). This fragment was
cloned into the EcoRV site of pBluescript. For the 1328 bp fragment
that corresponds to exons 3-13, we used the following primers: oBH-
33 (exon 6) (5 ¢ ACTTGACGATCCTTCTACTGC3 ¢ ) and oBH-31
(exon 13) (5¢ ATCCATCCATTGTCGACGCTGC3 ¢ ). For the 1146 bp
fragment we used the following primers: oBH-29 (Exon 1)
(5¢ ATGAATCGGATAGCGCGTCACTTACG3 ¢ ) and oBH-32 (exon
6) (5¢ TGTTTCCGAGAGCACTGACAGC3¢ ). Both of these products
were cloned (using an NcoI site in exon 6) into pSL1190, using the
EcoRV site as a blunt end site for the end opposite the NcoI site. RT-
PCR clones were sequenced to confirm that no mutations were
introduced in the PCR. We found no evidence for alternative splicing
of the ptp-3 locus, although our analysis was not exhaustive.
To test whether the genomic cosmid clone F38A3 could rescue
ptp-3 mutant phenotypes, we generated transgenic arrays by
transforming wild-type animals with F38A3 (2 ng/ m l) and the
plasmid pRF4 (30 ng/ m l), which confers a Roller phenotype. We
obtained several such extrachromosomal arrays in wild-type
background, then introduced these arrays into a vab-1(e2) ptp-
3(op147) mutant background by crossing. We homozygosed for the
vab-1 and ptp-3 mutations and confirmed homozygosity by
complementation tests for vab-1 and by PCR to detect op147::Tc1.
The e2 op147 double mutant displays approx. 81% embryonic
lethality. If the transgenic arrays completely rescued ptp-3 mutant
phenotypes the embryonic lethality in transgenic animals should be
at most suppressed to the level found in a vab-1(e2) ptp-3(+) strain,
which is approx. 10.2% (George et al., 1998). Of four such arrays,
three (juEx183, juEx184, juEx186) showed significant rescue of the
vab-1 ptp-3 synthetic lethality (Fig. 5); these arrays did not rescue
the phenotypes of vab-1(e2) single mutants (not shown). Two
integrated versions of juEx183, juIs138 and juIs139, were generated
by UV/trimethylpsoralen mutagenesis.
Identification of op147::Tc1
We identified a Tc1 insertion in the PTP-3 coding region by
screening the mutator strain MT3126 with primers specific to Tc1
and to the phosphatase domain of ptp-3, essentially as described
previously (Gutch et al., 1998). Two sets of ptp-3 primer pairs
(sequences available on request) were used with Tc1-specific
primers to screen 2880 cultures. A single Tc1 insertion mutation was
identified and worms homozygous for the insertion allele isolated.
The op147::Tc1 insertion allele was outcrossed 10 times to N2 prior
to phenotypic and genetic analyses. By sequencing the insertion site
we determined that Tc1 had inserted between nucleotides 9486 and
9487 of the F38A3 clone, the flanking sequence being 5 ¢
GAAGCT[op147::Tc1]ACATTG 3 ¢ .
Construction of PTP-3 GFP reporter genes and transgenic
strains
Construction of PTP-3B::GFP
To create the ptp-3B::GFP minigene, a unique Pst I site in the ptp-3B
cDNA immediately 3¢ to the coding region for the second phosphatase
domain was used to insert GFP coding sequence (GFP variant F64L
S65T, derived from vectors generously provided by A. Fire) in frame
with the PTP-3B protein (clone pBH8). A 14651 bp NcoI-NotI
fragment from cosmid F38A3, corresponding to the ptp-3B promoter
and exons 14-20 (Fig. 1A) was cloned into pSL1190 (pBH1). From
pBH8 a 5 kb NotI fragment was cloned into the NotI site of pBH1.
The resulting clone, pCZ406, contains genomic sequence for the
promoter and the first approx. 6.5 exons of PTP-3B; the second half
of exon 19 and subsequent exons are present as cDNA, tagged with
GFP.
We made two series of transgenic arrays containing the PTP-
3B::GFP minigene. The first series was formed by injection of
pCZ406 at high concentrations (50 ng/ m l), together with the marker
plasmid pRF4 (30 ng/ m l). Four such ‘high concentration’ arrays,
juEx188 through juEx191, gave robust GFP expression and caused
low-penetrance morphogenetic defects in wild-type genetic
backgrounds and sickness and inviability in vab-1 ptp-3 mutant
backgrounds. A second series of transgenes was therefore generated
by injection of the PTP-3B::GFP minigene at low concentrations (5
ng/m l), together with pRF4 (30 ng/ m l). Such ‘low concentration’
arrays gave weak GFP fluorescence; GFP expression in a pattern
similar to that of the high-concentration arrays could be detected by
immunostaining with anti-GFP antibodies (not shown). The low
concentration arrays (juEx222-juEx224) did not cause lethality in
wild-type or vab-1 ptp-3 mutant backgrounds and were used to assay
rescuing activity of the transgenes.
Construction of Pptp-3A::GFP 
A 5090 bp DNA fragment corresponding to the putative ptp-3A
promoter and ATG was amplified from N2 genomic DNA using Long
PCR (Boehringer Mannheim) and cloned into the PstI and BamHI
sites of pPD122.34 using sites engineered into the primers; sequences
of primers used are available on request. This construct was injected
into N2 hermaphodites at 50 ng/ m l with the pRF4 marker plasmid (30
ng/m l).
Tissue-specific expression of PTP-3B
To make constructs expressing PTP-3B under the control of the
unc-119 or jam-1 promoters we amplified appropriate promoter
regions using PCR and cloned them into constructs containing the
PTP-3B cDNA. Details of primer sequences and plasmid
constructions are available on request. Transgenic arrays were
established by coinjection of the appropriate promoter construct (5
ng/m l) and a SUR-5-GFP marker plasmid (30 ng/ m l) into N2 wild-
type animals. Arrays were introduced into a vab-1(e2) ptp-3(op147)
background by crossing and penetrance of morphogenetic phenotypes
quantitated as described above.
Anti-PTP-3 antibodies and immunostaining
A 2.1 kb PCR product corresponding to the entire PTP-3 intracellular
domain (residues 1509-2190) was amplified from the ptp-3 cDNA
using primers introducing NotI and SalI sites. The PCR product was
digested with NotI and SalI and cloned into pGEX4T-3 (Amersham),
yielding a clone that fuses the PTP-3 intracellular domain with GST.
The fusion protein antigen was purified from 6 liters of induced E.
coli DH5a using a protocol developed by Doug Kellogg (Carroll et
al., 1998), and used to immunize rabbits (Animal Pharm). Bleeds were
tested for immunoreactivity against purified GST-PTP-3. 10 ml
of serum from the most immunoreactive bleed was purified by
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adsorption to purified GST-PTP-3 blotted onto nitrocellulose,
followed by washing and dialysis into 1 · PBS, 50% glycerol,
following standard procedures (Harlow and Lane, 1999). The
resulting affinity purified serum was used at 1 in 100 dilution for
immunostaining. Staining was carried out using a version of the
Finney-Ruvkun fixation protocol (Finney and Ruvkun, 1990)
optimized for embryos. Embryos were immunostained with MH27
and anti-GFP antibodies as described previously (Chin-Sang et al.,
1999). Images were acquired on a Leica TCS-NT confocal
microscope or a Zeiss Axioplan 2.
RESULTS
The ptp-3 locus encodes two isoforms of a
C. elegans LAR-like RPTP
We identified the ptp-3 gene in a PCR-based screen for
C. elegans genes encoding protein tyrosine phosphatases
(Gutch et al., 1998). The genomic sequence of the ptp-3 locus
was determined by the C. elegans genome consortium, and is
contained in cosmid clones C09D8 and F38A3 (Fig. 1A).
Using northern blots of C. elegans mRNA we found that the
ptp-3 locus generates two major transcripts, of approximately
8 kb and 5 kb (Fig. 1B). We determined the sequences of
cDNAs corresponding to these two transcripts as described in
Materials and Methods. Comparison of ptp-3 cDNA and
genomic sequences revealed that the two transcripts have
common 3 ¢ sequences and differ in their 5¢ ends. This
difference arises from the use of alternative promoters and sets
of 5 ¢ exons, as shown in Fig. 1A. The long transcript encodes
a 2190 amino acid polypeptide designated PTP-3A, and the
shorter ptp-3 transcript encodes a 1487 residue polypeptide
designated PTP-3B. Exons 15 through 29 are common to both
transcripts and encode the C-terminal 1452 residues common
to both isoforms.
PTP-3A, like other LAR-like (type IIa) RPTPs, has an
extracellular domain consisting of three N-terminal
immunoglobulin-like (Ig) domains and eight fibronectin type
III (FNIII) repeats, and an intracellular domain containing two
protein-tyrosine phosphatase (PTP) domains. Within all these
domains, the closest relative to PTP-3A is DLAR; vertebrate
LAR-like proteins are slightly less similar (Fig. 2A,B). The
smaller isoform, PTP-3B, lacks the N-terminal Ig domains and
the four N-terminal FNIII repeats (Fig. 2A). Other LAR family
genes generate multiple isoforms by alternative splicing, but
none appears to use internal promoters to generate isoforms of
the same domain structure as PTP-3B.
PTP-3 isoforms are widely expressed in early
development and are later predominantly expressed
in the nervous system
To learn where PTP-3 was expressed during development we
generated animals expressing PTP-3::GFP transgenes (see
Materials and Methods). PTP-3B::GFP transgenes partly
rescued the defects of ptp-3 mutants (see below; Fig. 5A),
suggesting that it reproduces part of the endogenous PTP-3B
expression pattern. To identify the cells in which PTP-3A was
expressed we used transcriptional fusion constructs that
expressed GFP under the control of ptp-3A upstream
sequences.
PTP-3B::GFP transgenes showed widespread expression in
embryos. The earliest stage at which we detected GFP
fluorescence in these embryos was during late gastrulation
(approximately 250-300 minutes after first cleavage at 20°C).
PTP-3B::GFP expression was observed uniformly on the
surface of most, possibly all, cells in the embryo during
gastrulation cleft closure and epidermal enclosure (Fig. 3A,D).
In later embryos, larvae and adults PTP-3B::GFP expression
became highest in the nervous system, including the nerve ring,
dorsal cord, and ventral cord (Fig. 3G-I). PTP-3B::GFP was
expressed in many but not all neurons, within which it was
localized to neurites. In later embryos and larvae PTP-3B-GFP
became localized within epidermal cells, apparently to
adherens junctions (data not shown). The Pptp-3A::GFP
construct expressed GFP from the comma stage (380 minutes)
onwards in many neurons that also expressed PTP-3B::GFP
(data not shown). Thus, PTP-3 isoforms are expressed in many
tissues during early development, and later become restricted
to the nervous system and epithelial tissues. To determine the
expression of endogenous PTP-3 proteins we raised antibodies
against the intracellular domain of PTP-3; these antisera are
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Fig. 1. Structure of the ptp-3 locus. (A) Genomic
structure of the ptp-3 locus and location of op147::Tc1.
The long transcript, encoding PTP-3A, is generated from
29 coding exons that span 36.2 kb of genomic DNA; this
transcription unit is denoted C09D8.1 in the C. elegans
genome database (also previously known as clar, ypp-1,
and ptp-1). Four large introns are not shown to scale
(dotted lines). Exons 1-13 are specific to the long
transcript. Exon 14 contains the ATG for the short
transcript and is transcribed from an internal promoter.
Exon 13 (PTP-3A) or exon 14 (PTP-3B) both splice to
exon 15. Exons 15-30 are common to both transcripts.
The transmembrane domain (tm) and the D1 phosphatase
domain are encoded by exon 26. The Tc1 insertion of
op147 is in exon 26, disrupting the D1 phosphatase
domain. The PstI site used to insert GFP is indicated.
The genomic region contained in cosmid clone F38A3 is indicated. (B) Northern blot of total C. elegans mRNA extracted
from mixed-stage populations, probed with the PTP-3B cDNA (see Materials and Methods). Messages of approx. 8 kb and
approx. 5 kb are detected. (C) Partial genetic map of the center of linkage group II, showing map location of ptp-3, vab-1,
and markers used in strain constructions.
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expected to recognize both PTP-3 isoforms. The staining of
anti-PTP-3 antisera in wild-type animals (Fig. 3G) was weaker,
but otherwise identical in pattern to the expression pattern of
the PTP-3B::GFP transgenes.
Loss of ptp-3 function results in defects in
epidermal morphogenesis
We generated a Tc1 transposon insertion mutation, op147, that
disrupts the first phosphatase domain of PTP-3. This mutation
is therefore predicted to disrupt catalytic activity of both PTP-3
isoforms (see Materials and Methods). We show below that by
genetic criteria the op147 mutation behaves as a strong loss-
of-function mutation in ptp-3.
Most ptp-3(op147) mutant animals appeared wild-type in
morphology and behavior. The most obvious phenotype of ptp-
3(op147) mutants was a variable and incompletely penetrant
Fig. 2. PTP-3 is the C. elegans
ortholog of the LAR subfamily.
(A) Percentage identity and
similarity of PTP-3A
Immunoglobulin-like (Ig-like)
domains, Fibronectin Type III
(FNIII) repeats, and phosphatase
domains to those of its closest
relative (DLAR), and a
representative vertebrate LAR
family member (rat; RnLAR).
The PTP-3B isoform is also
shown for comparison; cartoons
are not to scale. DLAR contains a
ninth FNIII repeat; the FNIII
domains of PTP-3 align with the
first eight repeats of DLAR. PTP-
3A is the largest member of the
LAR family; the extra size is
mostly due to a larger ‘spacer’
region between the last FNIII
repeat and the predicted
transmembrane domain.
Percentages are calculated from
alignments using ClustalW.
(B) Alignment of the N-terminal
(D1) phosphatase domain of
PTP-3 with those of other LAR
family members (DLAR,
HmLAR2, and rat LAR), using
ClustalW. Within the phosphatase domains, DLAR is the most similar protein to PTP-3; within the vertebrate LAR family, PTP d proteins are
slightly more similar to PTP-3 than are LAR or PTP s . The op147 insertion disrupts codon Y1705 in the first phosphatase domain, between the
conserved residues YINAN and FWRM. The predicted catalytic cysteine residue C1833 is marked (asterisk). Accession numbers are M27700
(DLAR), AF017083 (HmLAR2), and S46216 (rat LAR). The sequences of PTP-3 cDNAs have been deposited in GenGank, with accession
numbers AF316539 (PTP-3A) and AF316540 (PTP-3B).
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Fig. 3. Embryonic and neuronal expression of PTP-3.
(A-F) Expression of PTP-3B-GFP in enclosure stage
embryos. Animals are of genotype juEx189; GFP is
visualized by anti-GFP immunostaining (green), animals are
also immunostained with MH27 to visualize adherens
junctions (red). (A-C) A lateral confocal projection of an
embryo prior to epidermal enclosure. The dorsal sheet of
epidermal cells is visualised by MH27 staining; PTP-
3B::GFP expression is widespread in surface cells;
expression in ventral neuroblasts is marked in A
(arrowhead). (D-F) A post-gastrulation embryo; medial
confocal section showing widespread expression of PTP-
3B::GFP at cell surfaces in epidermal, neuronal, pharyngeal,
muscle, and endodermal tissue layers. (G) Wild-type L1
larva stained with anti-PTP-3 antibodies and MH27. Nerve
ring staining is marked by the arrowhead. (H,I) PTP-3B-
GFP expression in L1 (H) and adult (I) (juEx189), stained
with anti-GFP antibodies; note intense nerve ring expression
(arrowhead in I) and staining in neuronal processes. Scale
bar, 10 m m (A-F); 30 m m (G, H); 100 m m (I).
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defect in epidermal morphogenesis (Table 1; Fig. 4). At 20°C,
85% of ptp-3 animals appeared morphologically wild type.
The remaining 15% displayed variable defects in epidermal
morphology; about one third of these animals arrested in
embryogenesis (see below); one third arrested during larval
development, and the remainder developed to adulthood. A
common morphological defect in ptp-3 larvae and adults was
a swelling or blunting of the posterior epidermis (Fig. 4A).
This ‘blunt posterior’ phenotype is similar to that observed in
some animals mutant for the VAB-1 Eph receptor tyrosine
kinase or the VAB-2/EFN-1 ephrin ligand (Fig. 4F). However,
the distinctive anterior morphology defects (‘Notched head’)
of vab-1 or vab-2 mutants were not seen in ptp-3 mutants,
which only occasionally displayed a swollen or pinched head
region (Fig. 4B). The op147 mutation is slightly temperature
sensitive (Table 1).
We asked whether op147 behaved genetically as a loss-of-
function mutation by examining the phenotypes of animals
heterozygous for op147 in trans to chromosomal deficiencies
spanning ptp-3 (Fig. 1C). Such op147/Df animals displayed a
similar range and penetrance of defects to those of op147
homozygotes (see Materials and Methods). dsRNA-mediated
interference of ptp-3 caused morphogenetic defects similar to
those of ptp-3(op147) mutants (see Materials and Methods).
Taken together, these data suggest that ptp-3(op147)
causes a strong loss of ptp-3 function. However, the
nature of the op147 lesion suggests that it may not be
a complete molecular null mutation in PTP-3, as Tc1
insertions in genes can be removed by splicing
(Rushforth and Anderson, 1996) or somatic excision
(Eide and Anderson, 1988). Consistent with this
possibility, extremely weak anti-PTP-3 staining was
observed in approx. 70% of ptp-3(op147) mutant
animals; in the remaining 30%, anti-PTP-3 staining
was completely absent. Finally, if PTP-3 has
phosphatase-independent functions then these may be
unaffected by op147.
To confirm that the mutant defects in op147 strains
were due to the op147 mutation, we asked whether transgenic
arrays containing ptp-3(+) genomic DNA could rescue op147
mutant phenotypes. Transgenes containing cosmid F38A3
rescued ptp-3 mutant phenotypes (Fig. 5A); because the ptp-
3(op147) phenotype is weak, we assayed rescue of vab-1 ptp-
3 synthetic lethal phenotypes (see Materials and Methods). The
F38A3 clone does not contain ptp-3 exons 1-4 (see Fig. 1A)
and thus cannot encode full-length PTP-3A. Thus,
overexpression of PTP-3B can partly rescue the defects of
ptp-3(op147) mutants. PTP-3B::GFP transgenes also displayed
partial rescuing activity, consistent with these genomic rescue
experiments (Fig. 5).
ptp-3 mutants are defective in embryonic neuroblast
and epidermal movements, but display normal axon
guidance in selected neurons
The epidermal morphogenetic defects of ptp-3 mutants arise
during embryogenesis, and are reminiscent of those seen in
vab-1 and efn-1 mutants. vab-1 (Eph receptor) and efn-1
(ephrin, previously vab-2) mutant embryos display defects in
two phases of embryonic cell movements: closure of the
ventral gastrulation cleft by short-range neuroblast movements,
and enclosure of the embryo by epidermal cell shape changes
(Chin-Sang et al., 1999; George et al., 1998). We therefore
asked whether ptp-3 mutant embryos were also defective in
these embryonic morphogenetic processes.
Using four-dimensional (4-D) microscopy we found that
ptp-3 mutant embryos were defective in both closure of the
gastrulation cleft and in epidermal enclosure (Fig. 6, second
and third rows). Of 37 ptp-3 mutant embryos recorded we
observed defects in gastrulation cleft closure in seven; six of
these seven subsequently failed to enclose the epidermis and
arrested at the early enclosure stage of morphogenesis. The
remaining 30 displayed normal gastrulation cleft closure and
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Fig. 4. Morphological phenotypes of ptp-3 mutants.
(A-D) Representative ptp-3(op147) mutant L1 stage larvae
(grown at 25°C) showing defects in morphogenesis. The
most common defect is a bulging or pinching of the
posterior body (A); however, pinched or notched heads are
also occasionally seen (B). Some inviable ptp-3(op147)
larvae are starved, apparently a result of defects in
pharyngeal morphogenesis (arrow in C). Some ptp-
3(op147) larvae are deformed along the entire body (D). A
wild-type L1 larva (E) and vab-1(null) mutant larva (F)
showing the head morphology defect are shown for
comparison. Scale bar, 13 m m (A-D), 20 m m (E,F).
Table 1. Penetrance of ptp-3(op147) visible and lethal
phenotypes
Embryonic Larval Deformed Wild-type 
Genotype, temperature (n) lethality lethality adult adult
ptp-3(op147) 15°C (746) 4.1% 5.8% 2.3% 87.8%
ptp-3(op147) 20°C (945) 5.3% 5.0% 3.7% 85.8%
ptp-3(op147) 22.5°C (669) 5.1% 1.3% 3.3% 90.2%
ptp-3(op147) 25°C (462) 11.6% 8.2% 3.8% 76.1%
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epidermal morphogenesis. The defects in ptp-3 mutants could
be classified using the same criteria as used to classify vab-1
or efn-1 embryonic phenotypes (see Fig. 6 legend). Thus, ptp-
3 mutant embryos display low-penetrance defects in
gastrulation and epidermal enclosure, similar to those observed
in vab-1 or efn-1 mutants.
Genetic analysis in Drosophila has implicated RPTPs in
axon guidance and fasciculation. We examined the process
morphology of selected neurons (mechanosensory neurons
and GABAergic motor neurons) in ptp-3 mutants using GFP
markers and found no significant defects in axon guidance
(data not shown). ptp-3(op147) mutants displayed normal
locomotion, feeding, defecation and egg-laying behavior.
With the caveat that ptp-3(op147) may not abolish PTP-3
function, these observations suggest that if ptp-3 functions in
axon guidance in C. elegans its functions are subtle or
redundant.
vab-1 and ptp-3 mutations have synergistic effects
on morphogenesis
Our data show that PTP-3 signaling and VAB-1 Eph RTK
signaling function in the same processes of embryonic
morphogenesis. To ask whether ptp-3 signaling interacted with
Eph receptor signaling we constructed strains containing ptp-
3(op147) and vab-1 null [vab-1(0)] mutations. The vab-1(0)
ptp-3 double mutant strains displayed strongly enhanced
morphogenetic defects compared to vab-1 null mutants.
vab-1(0) mutations alone result in approx. 50% embryonic
lethality and approx. 80% total lethality (George et al., 1998);
despite this high level of lethality, some animals are viable and
fertile, and vab-1 null mutant strains can be propagated as
homozygotes. In contrast, vab-1(0) ptp-3 double mutant
animals were completely inviable and always arrested during
embryogenesis. We analyzed the embryogenesis of such
double mutants using 4-D microscopy, and found that all
vab-1(0) ptp-3 double mutant animals displayed severe defects
in neuroblast movement during closure of the gastrulation cleft,
and consistently arrested during early epidermal enclosure
(Fig. 6, fourth row). These phenotypes correspond to the severe
Class I phenotype, observed in a small fraction of vab-1(0)
mutants (George et al., 1998). We did not observe any new
morphogenetic phenotypes in the double mutants. Because the
double mutants are more strongly affected than expected from
additivity of mutant phenotypes these data indicate that VAB-1
and PTP-3 play related and partly redundant roles in
morphogenesis.
The synergistic effects of vab-1 and ptp-3 mutations on
morphogenesis could reflect their redundant function in the
same set of cells or in different sets of cells. VAB-1 is
expressed and required in neuroblasts and neurons during
embryogenesis, whereas PTP-3 shows a more widespread
distribution. We used tissue-specific promoters to ask whether
PTP-3 function was required in neurons or in epidermal cells
in a vab-1 ptp-3 mutant background. Only expression of PTP-3
under the control of the pan-neural unc-119 promoter caused
a significant decrease in the lethality of vab-1 ptp-3 double
mutants (Fig. 5B). Expression of PTP-3 using epidermal
promoters gave partial rescue that was not statistically
significant. We conclude that one focus for the synergistic
effects of VAB-1 and PTP-3 on epidermal development is
the developing nervous system, although the partial rescue
observed might indicate that PTP-3 functions in both neuronal
and epidermal cells.
PTP-3 may function redundantly with kinase-
dependent and kinase-independent functions of
VAB-1
Mutations predicted to eliminate VAB-1 kinase activity
[vab-1(k) mutations] do not cause complete loss of VAB-1
function, leading to the model that VAB-1 has both kinase-
dependent and kinase-independent functions (George et al.,
1998). The kinase-independent function of VAB-1 may involve
signaling via the ephrin VAB-2/EFN-1 (Chin-Sang et al.,
1999; Wang et al., 1999). We used double mutant analysis to
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Fig. 5. Transgenic rescue of vab-1 ptp-3 synthetic lethality by PTP-
3B. Embryonic lethality was quantitated in transgenic strains as
described in Materials and Methods. All strains are homozygous for
vab-1(e2) and ptp-3(op147). (A) ptp-3(+) transgenes (4 lines)
contain the cosmid F38A3; PTP-3B::GFP transgenes (3 lines)
contain the PTP-3B::GFP transgene injected at low concentration
(see Materials and Methods). The vab-1 ptp-3 synthetic lethality is
suppressed in lines containing these transgenes, relative to control
extrachromosomal arrays containing the pRF4 marker plasmid
(juEx195). Data for vab-1(e2) (George et al., 1998) are shown for
comparison. (B) Suppression of vab-1 ptp-3 synthetic lethality by
neuronally expressed PTP-3B (juEx377-379) but not by epidermally
expressed PTP-3B (juEx422-424). Only arrays juEx378 and juEx379
caused significant reduction in lethality (Student’s t-test, P<0.01).
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determine whether PTP-3 function is redundant with one or
both of these VAB-1 pathways.
We found that the phenotypes of vab-1 kinase mutants were
dramatically enhanced by loss of ptp-3 function (Fig. 6, Fig.
7A). vab-1(k) mutations in a ptp-3(+) background cause
approx. 10% embryonic lethality (George et al., 1998),
whereas vab-1(k) ptp-3(op147) double mutants displayed 80-
100% embryonic lethality, depending on the vab-1(k) allele
used. We analyzed vab-1(k) ptp-3 double mutants using 4-D
microscopy and confirmed that this enhancement was due to
increased penetrance and severity of embryonic morphogenetic
defects seen in the single mutants (Fig. 6, bottom row). We
conclude that ptp-3 functions redundantly with the kinase-
dependent function of VAB-1.
Because vab-1(0) ptp-3 double mutants are more severely
affected than vab-1(k) ptp-1 double mutants, we reasoned that
PTP-3 function must also be redundant with the VAB-1 kinase-
independent pathway. To address this possibility we made
double mutants between ptp-3(op147) and vab-1 missense
mutations affecting the extracellular domain. Extracellular
domain missense alleles of VAB-1 such as e699 cause stronger
phenotypes than vab-1(k) alleles. However, vab-1(e699)
showed weaker interactions with ptp-3 than did the vab-1(k)
alleles, although the double mutants were more severely
affected than expected from additivity (Fig. 7A). These data
are consistent with PTP-3 also functioning redundantly with
the kinase-independent function of VAB-1.
ptp-3 mutations synergize with efn-1 ephrin
mutations but not with efn-2 or efn-3 mutations
From the synergistic genetic interactions of ptp-3 and vab-1
mutations we conclude that PTP-3 and VAB-1 play related and
partly redundant roles in morphogenesis. We therefore
investigated if PTP-3 displayed genetic interactions with the
ephrin ligands for VAB-1. Mutations in three ephrins (EFN-1,
EFN-2 and EFN-3) have been identified in C. elegans; genetic
and biochemical analysis indicates that these ligands function
in both the kinase-dependent and kinase-independent VAB-1
pathways (Chin-Sang et al., 1999; Wang et al., 1999). Mutations
in the ephrin EFN-1 cause defects in gastrulation and epidermal
enclosure similar to those of vab-1 mutants. We found that ptp-
3; efn-1 double mutants displayed synergistic enhancement
(Fig. 7B), although the double mutant strains displayed a
different range of phenotypes from those of vab-1(k) ptp-3
double mutants, in that many animals arrested during larval as
opposed to embryonic development. EFN-1 may function both
in VAB-1 kinase-dependent and kinase-independent pathways
(Chin-Sang et al., 1999; Wang et al., 1999). The synergism of
ptp-3 with vab-1(e699) and with efn-1 confirms that ptp-3
function is redundant with both VAB-1 pathways.
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Fig. 6. Time-lapse analysis of
morphogenesis in ptp-3 mutants
and vab-1 ptp-3 double mutants.
Time series from five different
embryos are shown: the first row
is wild type; the second and
third rows depict two
representative ptp-3(op147)
embryos; the fourth row shows a
vab-1(dx31) ptp-3(op147)
embryo (vab-1(0) double
mutant), and the fifth row shows
a typical vab-1(e2) ptp-3(op147)
embryo (vab-1(k) double
mutant). All panels are ventral
views, with anterior to the left.
First column: beginning of
closure of the ventral
gastrulation cleft (approx. 230-
250 minutes after first cleavage);
note the enlarged gastrulation
cleft (arrowheads) in all mutant
genotypes. Second column: later
closure of gastrulation cleft.
Third column: early epidermal
enclosure. Fourth column: mid-
epidermal enclosure. Times for
each series are relative to the
frame in the first column. Of the
two ptp-3 embryos shown, the
upper series shows a severely
affected embryo, with enlarged
gastrulation cleft and early
failure in epidermal enclosure; this animal arrested at the enclosure stage, corresponding to the Class I phenotype of vab-1 mutants (George et
al., 1998). The lower ptp-3 series shows an embryo with slightly enlarged gastrulation cleft; this embryo underwent normal epidermal enclosure
and hatched with normal morphology, corresponding to the Class V phenotype of vab-1 or vab-2 embryos. Both vab-1 ptp-3 embryos shown
displayed defects in gastrulation cleft closure and arrested at epidermal enclosure.
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The ephrins EFN-2 and EFN-3 have minor roles in
embryogenesis, as loss of efn-2 or efn-3 function causes only
mild defects in morphogenesis (Wang et al., 1999). ptp-3; efn-2
and ptp-3; efn-3 double mutants and a ptp-3; efn-2; efn-3
triple mutant did not show synergistic enhancement of
morphogenetic defects (Fig. 7B). We conclude that PTP-3
functions redundantly with EFN-1, but not with EFN-2 or
EFN-3, in regulating embryonic morphogenesis.
Specificity of the synergistic interaction of vab-1
and ptp-3 mutations
Does the synergistic enhancement of vab-1 or efn-1 phenotypes
by ptp-3 reflect a specific interaction between the VAB-1 Eph
RTK and PTP-3/LAR pathways? To address this question, we
first asked whether ptp-3 displayed genetic interactions with a
another C. elegans RTK, the FGFR homolog EGL-15, which
functions in cell migration (DeVore et al., 1995). We found that
ptp-3; egl-15 double mutants displayed additive phenotypes, in
that egl-15 egg-laying phenotypes were neither enhanced nor
suppressed (data not shown), suggesting that PTP-3 does not
function synergistically or antagonistically with EGL-15/
FGFR signaling. Because LAR has been shown to negatively
regulate insulin receptor signaling in cell culture (Kulas et al.,
1996), we also asked whether ptp-3 displayed genetic
interactions with the C. elegans insulin receptor homolog
DAF-2 (Kimura et al., 1997). daf-2 mutations cause a dauer-
constitutive phenotype at 25°C; a ptp-3; daf-2 double mutant
strain also displayed a dauer-constitutive phenotype at the
restrictive temperature (data not shown), suggesting that ptp-3
may not repress insulin receptor signaling in C. elegans.
We also asked whether mutations in another RPTP displayed
genetic interactions with vab-1. The only other C. elegans
RPTP for which mutations are known is the Type II RPTP
CLR-1, which functions antagonistically with EGL-15 (Kokel
et al., 1998). vab-1 clr-1 double mutants displayed at most a
mild enhancement of the Vab-1 embryonic lethal phenotype;
clr-1 ptp-3 double mutants similarly displayed a mild
enhancement of Ptp-3 phenotypes (Fig. 7C). In Drosophila,
DLAR and the CLR-1-like phosphatase DPTP69D function
redundantly in some contexts; in contrast, our data suggest that
the incomplete penetrance of ptp-3 or vab-1 phenotypes does
not reflect redundancy with CLR-1.
While these data suggest that the interaction of PTP-3 and
VAB-1 reflects redundant functions of those specific pathways,
it remained possible that loss of function in ptp-3 might
non-specifically enhance the defects of other epidermal
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Fig. 7. Synergism of ptp-3 with vab-1 and vab-2
and lack of synergism with ina-1 or clr-1.
(A) Lethality was quantitated as described in
Materials and Methods; error bars show s.e.m.
Strains were raised at 20°C unless indicated. Data
for vab-1 are from George et al. (George et al.,
1998). Strains doubly mutant for ptp-3(op147)
and weaker vab-1 kinase alleles (the missense
alleles e2 and ju63) showed partially penetrant
synergistic lethality yet were viable as
homozygotes; strains containing stronger kinase
alleles were completely inviable as double
mutants with op147 (not shown). (B) Synergism
of ptp-3 with efn mutations. Data for efn-1 from
Chin-Sang et al. (Chin-Sang et al., 1999). Only
efn-1 displays synergistic lethality with ptp-3.
Over 90% of the lethality in vab-1(kinase) ptp-3
double mutants occurred during embryogenesis,
whereas vab-1(e699) and efn-1 double mutants
displayed approx. 60% embryonic lethality and
approx. 30% larval lethality. (C) Synergism of the
RPTP clr-1 with vab-1 or ptp-3 was tested using
the temperature-sensitive clr-1(e1745), which is
fully viable at 15°C and 20°C and is a fully
penetrant late larval lethal at 25°C. vab-1 clr-1
homozygotes were viable at 20°C; clr-1 ptp-3
strains were viable at 15°C but not at 20°C,
possibly suggestive of a mild enhancement of the
Clr-1 phenotype. Embryonic lethality was
quantitated using balanced strains of genotype
clr-1/mIn1 mIs14, vab-1 clr-1/mIn1 mIs14, and
clr-1 ptp-3/mIn1 mIs14. Strains were raised at
25°C and the embryonic lethality of non-GFP-
expressing animals quantitated.
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morphogenesis mutants. To address this possibility we made
animals doubly mutant for ptp-3 and a weak allele of the
a -integrin INA-1 (Baum and Garriga, 1997). Like VAB-1,
INA-1 is expressed in the nervous system, and loss of ina-1
function causes morphogenetic defects in the epidermis. We
found that ptp-3; ina-1 double mutants displayed additive
effects (Fig. 7A). These data suggest that PTP-3 and INA-1
have independent functions in morphogenesis, and that loss of
PTP-3 function does not enhance all morphogenetic mutants.
DISCUSSION
The evolution of LAR-like RPTPs
The LAR-like RPTPs have been highly conserved in animal
evolution. LAR-like RPTPs have been identified in vertebrates,
Drosophila (DLar), leeches (HmLAR1, HmLAR2),
protochordates (Matthews et al., 1991), and now in nematodes.
In all vertebrate species examined, three LAR subfamily
RPTPs are expressed: LAR itself, and the closely related
proteins PTPs and PTPd . The Drosophila and C. elegans
genomes each contain a single LAR-like gene, whereas the
leech Hirudo medicinalis expresses two LAR-family genes,
HmLAR1 and HmLAR2 (Gershon et al., 1998). Ancestral
metazoans may thus have expressed a single LAR-like gene
that became duplicated in the annelid and vertebrate lineages.
Vertebrate LAR subfamily genes are expressed in distinct
but partly overlapping patterns, both in the developing and
adult nervous systems and in a variety of non-neuronal tissues
(Schaapveld et al., 1998). Like its vertebrate orthologs, PTP-3
displays widespread, almost ubiquitous expression in early
C. elegans embryos. PTP-3 later becomes localized to neuronal
processes, as found for other vertebrate and invertebrate LAR
family members (e.g. Tian et al., 1991). Outside the nervous
system LAR-like proteins are often found in proliferating
epithelia, such as those of the lung and gut. In some mature
C. elegans epidermal cells PTP3 appears to localize to
adherens junctions; vertebrate LAR and PTP s proteins are also
found in adherens junctions (Aicher et al., 1997), where they
interact with b -catenin (Kypta et al., 1996). The potential role
of PTP-3 in epidermal adherens junctions is unclear, as ptp-3
mutant phenotypes do not resemble those resulting from loss
of function in the catenin/cadherin complex (Costa et al.,
1998); furthermore, loss of function in ptp-3 did not enhance
or suppress the phenotypes of loss-of-function mutations in
other adherens junction proteins such as HMP-1 (data not
shown).
Most LAR family genes generate multiple transcripts and
encode multiple protein isoforms, although the way in which
these isoforms arise is apparently not conserved between
animal phyla. Vertebrate LAR, PTP s , and PTP d genes all
undergo alternative splicing involving exons encoding both
extracellular and intracellular domains (O’Grady et al., 1994;
Zhang and Longo, 1995). Many LAR family isoforms differ
only within their extracellular domains, suggesting that the
different isoforms could interact differently with ligands. For
example, inclusion of a small exon within FNIII repeat 5
modulates the binding of LAR to laminin-nidogen (O’Grady
et al., 1998).
We have shown that the C. elegans ptp-3 gene encodes at
least two isoforms, PTP-3A and PTP-3B, by use of alternative
promoters; this genomic organization has so far not been found
in other LAR genes. Our anti-PTP-3 antibodies, which should
recognize both isoforms, showed staining weaker than that of
an isoform-specific PTP-3B::GFP transgene but otherwise
indistinguishable, implying that both isoforms are expressed in
similar patterns. The ptp-3(op147) insertion allele affects a
phosphatase domain common to both isoforms and should
decrease the function of both isoforms, although it may not
affect phosphatase-independent functions of PTP-3, as
proposed for Drosophila Lar (Maurel-Zaffran et al., 2001).
Transgenes encoding only PTP-3B can rescue most or all of
the defects observed in ptp-3 mutants, suggesting that PTP-3B
function is necessary for morphogenesis. Consistent with this
hypothesis, a deletion mutation that specifically disrupts the
PTP-3A isoform (K. Gengyo-Ando and S. Mitani, personal
communication) does not cause defects in embryonic
morphogenesis and does not synergize with vab-1 mutations
(data not shown). PTP-3A might have no function in
embryonic morphogenesis, or its functions might be redundant
with PTP-3B, such that only mutations disrupting both
isoforms cause morphogenetic defects. 
The functions of LAR-like RPTPs
Work on Drosophila has established that LAR-like RPTPs
function in axon guidance and fasciculation. In Drosophila,
some Lar mutant phenotypes are synergistically enhanced in
double mutant combinations with two other RPTPs, DPTP69D
and DPTP99A, showing that the partial penetrance of LAR null
mutant defects reflects redundant functions of these RPTPs
(Desai et al., 1997). Genetic interactions indicate that in
Drosophila neural RPTPs also function as positive regulators
of Robo/Slit-based growth cone repulsion from the midline
(Sun et al., 2000a). Mutations in murine LAR-like RPTPs
cause subtle defects in neural tissues, although it is unclear if
these reflect defects in axon guidance. The three vertebrate
LAR-like RPTPs have overlapping expression patterns,
suggesting that the subtle phenotypes of LAR, PTP s , and
PTP d mutants could reflect redundant functions of these
RPTPs. We have found that in C. elegans LAR plays a subtle
role in early neural and epidermal development, as reflected by
the mild defects of ptp-3 mutants. The mild phenotypes of LAR
mutants in Drosophila, mice and C. elegans suggest the
possibility that these proteins function in highly redundant
signaling processes.
Our analysis of ptp-3 mutant phenotypes has revealed that
PTP-3 and Eph signaling are required in similar processes of
embryogenesis. Loss of function in PTP-3, in the Eph receptor
VAB-1, or in the ephrin ligand EFN-1, causes incompletely
penetrant defects in neuroblast movements during closure of
the gastrulation cleft, and in later epidermal morphogenesis. In
vab-1 ptp-3 double mutants the penetrance and severity of
these defects are dramatically enhanced, although no new
defects are seen in the double mutants. The simplest
interpretation of this synergistic genetic interaction is that PTP-
3 and VAB-1 function in closely related pathways, and that
these pathways have partly redundant functions in controlling
neuroblast movements. In contrast to the extremely variable
defects of vab-1(0) or ptp-3 single mutants, vab-1(0) ptp-3
double mutants display a consistent arrest at early epidermal
enclosure. This suggests that the variability of the single
mutant phenotypes reflects compensation by the other
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pathway; that is, the variability of the Vab-1 null phenotype
reflects the ability of PTP-3 signaling to partly compensate for
lack of VAB-1, and vice versa. The synergistic interaction of
ptp-3 with efn-1 mutations is consistent with previous data
showing that EFN-1 functions in the VAB-1 pathway in
embryonic morphogenesis (Chin-Sang et al., 1999). ptp-3 does
not show similar synergistic lethal interactions with ephrins
efn-2 and efn-3, consistent with their relatively minor roles in
embryogenesis (Wang et al., 1999).
Because vab-1 and ptp-3 mutants display defects in the
movements of ventral neuroblasts during gastrulation cleft
closure, we favor the hypothesis that VAB-1 and PTP-3
function redundantly within the same sets of neuronal
precursors. This hypothesis is supported by our tissue-specific
expression data. Significant rescue of vab-1 ptp-3 mutant
phenotypes was only observed when PTP-3B was expressed
using a pan-neural promoter and not when using epithelial or
epidermal-specific promoters. While these experiments do not
address whether VAB-1 and PTP-3 function in the same
individual neurons, they are consistent with VAB-1 and PTP-3
functioning in the same tissue. The incomplete rescue observed
in these experiments could reflect failure to accurately
reproduce the endogenous PTP-3 expression pattern, or it
could reflect an additional role for PTP-3 in epidermal cells.
Several PTPs, including LMW-PTP, FAP-1, and SHP-2,
appear to function downstream of Eph receptors (Lin et al.,
1999; Miao et al., 2000; Stein et al., 1998). Although PTP-3 is
unlikely to function directly in the VAB-1/Eph receptor
signaling pathway, this is to our knowledge the first indication
of a specific genetic interaction between a receptor-like PTP
and Eph pathways. Our proposal that a receptor PTP and
receptor PTK function redundantly in promoting signaling
through a common pathway raises the question of the
mechanism by which this may be achieved by two apparently
antagonistic enzymes. While there are abundant examples of
PTPs antagonizing PTK-dependent signaling pathways, there
are also many examples of PTPs that function positively to
promote signaling. For example, CD45, the prototypic receptor
PTP, plays an essential positive role in signaling through T and
B cell receptors (Neel, 1997) and PTP- a promotes signaling
events associated with cell growth (Zheng et al., 1992). In both
cases, the PTPs appear to dephosphorylate an inhibitory site of
tyrosine phosphorylation at the C terminus of Src family PTKs,
activating the kinase. Thus, a PTP can function in concert with
a PTK to promote tyrosine phosphorylation. The SH2-domain-
containing phosphatase SHP-2, and its Drosophila homologue
Csw, function positively in several RTK pathways (Allard et
al., 1996; Perkins et al., 1996). In the case of the RTK Torso,
Csw can promote signaling by dephosphorylation of inhibitory
phosphotyrosines in the Torso cytoplasmic domain (Cleghon
et al., 1998). We think it unlikely that PTP-3 acts via
dephosphorylation of VAB-1, as PTP-3 mutations have
dramatic effects in a VAB-1 null mutant background. PTP-3
might promote signaling in the VAB-1 pathway by
dephosphorylation of a downstream substrate; elucidation of
the substrates of PTP-3 will be required to test this possibility.
LAR-like RPTPs and Eph RTKs have been implicated in
related aspects of cellular behavior in other organisms. Both
Eph RTKs and LAR can cause axonal growth cone collapse
(Baker and Macagno, 2000; Drescher et al., 1995), and thus
can promote repulsive interactions between growth cones and
their substrates (Orioli and Klein, 1997). However, in some
situations LAR-like RPTPs may promote cell adhesion or
growth-cone attraction, rather than repulsion (e.g. Sun et al.,
2000b), suggesting that Eph signaling and LAR signaling
could play antagonistic or synergistic roles depending on the
specific cellular context. Our finding that Eph signaling and
LAR play related and partly redundant roles in C. elegans
morphogenesis suggests that these two pathways may also be
intimately connected in other organisms.
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